Literature DB >> 11307046

Gabapentin-induced hypersensitivity syndrome.

M V Ragucci1, J M Cohen.   

Abstract

Hypersensitivity syndrome is a rare but potentially fatal reaction to some pharmacologic agents, including some antiepileptic drugs. Typically, the syndrome presents with fever, rash, tender lymphadenopathy, hepatitis, and eosinophilia. We report a novel case of clinical hypersensitivity syndrome secondary to gabapentin. A patient developed altered mental status, fever, diffuse macular rash, and an enlarged spleen. This constellation of symptoms and signs began 9 days after gabapentin therapy was begun. Quick resolution was noted after gabapentin was discontinued. To our knowledge, there are no reports of hypersensitivity syndrome to gabapentin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11307046     DOI: 10.1097/00002826-200103000-00007

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  3 in total

1.  Cutaneous pseudolymphoma secondary to gabapentin.

Authors:  Andrew J Newman; Dustin Mullens; Christopher Pulford; Travis Lam
Journal:  BMJ Case Rep       Date:  2018-10-21

Review 2.  Cutaneous Adverse Effects of Neurologic Medications.

Authors:  Eman Bahrani; Chloe E Nunneley; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 6.497

3.  Paradoxical effects of continuous high dose gabapentin treatment on autonomic dysreflexia after complete spinal cord injury.

Authors:  Khalid C Eldahan; Hannah C Williams; David H Cox; Jenna L Gollihue; Samir P Patel; Alexander G Rabchevsky
Journal:  Exp Neurol       Date:  2019-10-31       Impact factor: 5.620

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.